Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$12.19
-3.98%
Mkt Cap $1.77B
Analyst Ratings
Buy
8
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
Implied Upside
+92.9%
Consensus $23.50 vs current $12.19
NASDAQ·Healthcare·Biotechnology
$12.19
-3.98%
Mkt Cap $1.77B
Buy
8
Hold
6
Sell
2
Price Target (55 analysts)
$23.50
Range $9.00 – $49.00
+92.9%
Consensus $23.50 vs current $12.19